OTC Markets OTCPK - Delayed Quote USD
Xvivo Perfusion AB (publ) (XVIPF)
At close: October 15 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
642,949.00
597,542.00
415,292.00
258,386.00
179,861.00
--
Cost of Revenue
167,549.00
152,431.00
118,336.00
70,107.00
50,131.00
--
Gross Profit
475,400.00
445,111.00
296,956.00
188,279.00
129,730.00
--
Operating Expense
462,218.00
439,715.00
292,501.00
207,021.00
173,916.00
--
Operating Income
13,182.00
5,396.00
4,455.00
-18,742.00
-44,186.00
--
Net Non Operating Interest Income Expense
86,098.00
80,441.00
1,029.00
19,471.00
-482.00
--
Pretax Income
107,964.00
94,521.00
22,314.00
6,665.00
-57,263.00
--
Tax Provision
7,535.00
2,701.00
3,887.00
-1,487.00
-13,528.00
--
Net Income Common Stockholders
100,429.00
91,820.00
18,427.00
8,152.00
-43,735.00
--
Diluted NI Available to Com Stockholders
100,429.00
91,820.00
18,427.00
8,152.00
-43,735.00
--
Basic EPS
3.31
3.07
0.62
0.28
-1.61
--
Diluted EPS
3.31
3.07
0.62
0.28
-1.61
--
Basic Average Shares
30,352.04
29,935.15
29,525.95
28,845.69
27,171.35
--
Diluted Average Shares
30,352.04
29,935.15
29,525.95
28,936.08
27,354.52
--
Total Operating Income as Reported
11,973.00
4,187.00
6,409.00
-18,498.00
-45,675.00
--
Total Expenses
629,767.00
592,146.00
410,837.00
277,128.00
224,047.00
--
Net Income from Continuing & Discontinued Operation
100,429.00
91,820.00
18,427.00
8,152.00
-43,735.00
--
Normalized Income
101,360.14
92,790.97
18,644.46
8,184.55
-43,735.00
--
Interest Income
--
8,850.00
2,123.00
--
80.00
--
Interest Expense
--
1,190.00
605.00
276.00
361.00
--
Net Interest Income
86,098.00
80,441.00
1,029.00
19,471.00
-482.00
--
EBIT
103,497.00
95,711.00
22,919.00
6,941.00
-56,902.00
--
EBITDA
103,497.00
172,061.00
65,086.00
39,198.00
-26,864.00
--
Reconciled Cost of Revenue
167,549.00
152,431.00
118,336.00
70,107.00
50,131.00
--
Reconciled Depreciation
--
76,350.00
42,167.00
32,257.00
30,038.00
--
Net Income from Continuing Operation Net Minority Interest
100,429.00
91,820.00
18,427.00
8,152.00
-43,735.00
--
Total Unusual Items Excluding Goodwill
-1,001.00
-1,001.00
-262.00
-41.00
-9,873.00
--
Total Unusual Items
-1,001.00
-1,001.00
-262.00
-41.00
-9,873.00
--
Normalized EBITDA
104,498.00
173,062.00
65,348.00
39,239.00
-26,864.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-69.86
-30.03
-44.54
-8.45
--
--
12/31/2019 - 7/21/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade